<p>Kura Oncology Inc. has granted nonstatutory stock options to purchase 69,750 shares of common stock to four new employees under its 2023 Inducement Option Plan. Each option has an exercise price of $8.27 per share, reflecting the closing price of the company’s common stock on February 2, 2026. The options will vest over four years, with 25% vesting on the one-year anniversary of the vesting commencement date and the remaining shares vesting monthly over the following 36 months, contingent on continued service with the company. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9649783) on February 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

ARKG

Reuters

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

Health Care Select Sector SPDR

SPDR S&P Biotech

Kura Oncology

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

iShares US Pharma

ALPS Medical Breakthrough

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

VG Health

Invesco Biotechnology & Genome ETF

Kura Oncology Grants Stock Options to New Employees Under Inducement Plan